| Date | Title | Description |
| 20.09.2024 | ADDvise receives order worth USD 1.3 million | ADDvise receives order worth USD 1.3 million
Fri, Sep 20, 2024 14:20 CET Report this content
ADDvise Group’s subsidiary MRC Systems has received an order from Medsept. The company is a medical device manufacturer for the healthcare industry... |
| 17.09.2024 | Saab's Strategic Leap: Next-Gen Defense Solutions for Global Markets | In the ever-evolving landscape of defense technology, Saab stands as a beacon of innovation. Recently, the Swedish defense giant has made significant strides, delivering advanced systems that enhance military capabilities across the globe. ... |
| 11.09.2024 | ADDvise receives order worth SEK 32.5 million | ADDvise receives order worth SEK 32.5 million
Wed, Sep 11, 2024 11:15 CET Report this content
ADDvise Group’s subsidiary Germa has received an order from Saab AB (publ). The order has a total value of approximately SEK 32.5 million.
The ord... |
| 27.08.2024 | Fredrik Celsing appointed new chairman of the board of directors as of 1 September – extraordinary general meeting on 29 August cancelled | Fredrik Celsing appointed new chairman of the board of directors as of 1 September – extraordinary general meeting on 29 August cancelled
Tue, Aug 27, 2024 16:00 CET Report this content
ADDvise Group AB has previously convened an extraordin... |
| 27.07.2024 | Shifting Shares: A New Era for ADDvise | In the world of business, change is the only constant. The recent transactions involving ADDvise, a prominent player in the life sciences sector, illustrate this truth vividly. The chairman of the board and incoming CEO, Staffan Torstensson... |
| 25.07.2024 | Chairman of the board and incoming CEO of ADDvise divests shares of series A and acquires shares of series B | Chairman of the board and incoming CEO of ADDvise divests shares of series A and acquires shares of series B
Thu, Jul 25, 2024 18:22 CET Report this content
The chairman of the board and incoming CEO Staffan Torstensson has today, privately... |
| 24.07.2024 | Departing CEO of ADDvise divests shares of series A to a major shareholder of ADDvise | Departing CEO of ADDvise divests shares of series A to a major shareholder of ADDvise
Wed, Jul 24, 2024 15:50 CET Report this content
The departing CEO Rikard Akhtarzand has agreed with Kenneth Lindqvist, one of the major shareholders of AD... |
| 18.07.2024 | Interim report 2024, January 1 – June 30 | Interim report 2024, January 1 – June 30
Thu, Jul 18, 2024 07:45 CET Report this content
The second quarter saw continued robust revenue growth and improved profit. Organic growth remains burdened by challenging comparables from 2023 driven... |
| 18.07.2024 | Notice to extraordinary general meeting of ADDvise Group AB (publ) | Notice to extraordinary general meeting of ADDvise Group AB (publ)
Thu, Jul 18, 2024 06:30 CET Report this content
ADDvise Group AB (publ), reg. no. 556363–2115, hereby convenes the extraordinary general meeting on 29 August 2024 at 10:00 C... |
| 17.07.2024 | Staffan Torstensson is appointed new CEO of ADDvise. The CFO and incoming CEO is leaving | Staffan Torstensson is appointed new CEO of ADDvise. The CFO and incoming CEO is leaving
Wed, Jul 17, 2024 19:45 CET Report this content
The board of directors of ADDvise Group announces today that the chairman of the board, Staffan Torsten... |
| 04.07.2024 | Invitation to presentation of interim report January 1 – June 30, 2024 | Invitation to presentation of interim report January 1 – June 30, 2024
Thu, Jul 04, 2024 14:00 CET Report this content
ADDvise Group’s interim report for the period January 1 – June 30, 2024 will be published on July 18, 2024 at 07:45 (CEST... |
| 21.05.2024 | ADDvise receives order worth USD 1.4 million | ADDvise receives order worth USD 1.4 million
Tue, May 21, 2024 12:30 CET Report this content
Axelerist, an ADDvise Group company, has received an order from Vertex Pharmaceuticals, a global biotechnology company, for the sale and rental of ... |
| 07.05.2024 | ADDvise Group plans to change listing venue to Nasdaq Stockholm main market | ADDvise Group plans to change listing venue to Nasdaq Stockholm main market
Tue, May 07, 2024 08:30 CET Report this content
ADDvise Group AB (publ) ("ADDvise Group") has initiated the process of listing the company's A and B share... |
| 03.05.2024 | Report from the annual general meeting of ADDvise Group AB (publ) on 3 May 2024 | Report from the annual general meeting of ADDvise Group AB (publ) on 3 May 2024
Fri, May 03, 2024 12:08 CET Report this content
ADDvise Group AB (publ), reg. no. 556363-2115, has held its annual general meeting on 3 May 2024 at 10 a.m. CEST... |
| 02.05.2024 | Oliver Humlen is appointed new CEO of ADDvise Group, succeeding Rikard Akhtarzand who will transition to a board and active shareholder role | Oliver Humlen is appointed new CEO of ADDvise Group, succeeding Rikard Akhtarzand who will transition to a board and active shareholder role
Thu, May 02, 2024 14:00 CET Report this content
ADDvise Group has appointed Oliver Humlen as new CE... |
| 02.05.2024 | ADDvise receives order worth USD 11.3 million | ADDvise receives order worth USD 11.3 million
Thu, May 02, 2024 07:30 CET Report this content
MRC Systems, an ADDvise Group company, has received an order from leading Omani biopharmaceutical company Opal Bio Pharma. The initial order value... |
| 25.04.2024 | ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm | ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm
Thu, Apr 25, 2024 17:16 CET Report this content
On 4 April 2024, ADDvise Group AB (publ) (“ADDvise”) issued senior secured bonds in an amount of ... |
| 18.04.2024 | Interim report 2024, January 1 – March 31 | Interim report 2024, January 1 – March 31
Thu, Apr 18, 2024 07:45 CET Report this content
The first quarter saw a continued favourable revenue development. The Lab segment delivered strong organic growth whereas our pharmaceuticals business... |
| 05.04.2024 | ADDvise receives allocation decision worth EUR 1.25 million | ADDvise receives allocation decision worth EUR 1.25 million
Fri, Apr 05, 2024 15:30 CET Report this content
ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from the Kanta-Häme region worth EUR 1.25 million.... |
| 04.04.2024 | Invitation to presentation of interim report January 1 – March 31, 2024 | Invitation to presentation of interim report January 1 – March 31, 2024
Thu, Apr 04, 2024 10:28 CET Report this content
ADDvise Group’s interim report for the period January 1 – March 31, 2024 will be published on April 18, 2024 at 07:45 (C... |
| 03.04.2024 | ADDvise Group publishes annual report and sustainability report for 2023 | ADDvise Group publishes annual report and sustainability report for 2023
Wed, Apr 03, 2024 08:30 CET Report this content
Today, ADDvise Group AB (publ) is publishing the annual report and the sustainability report for 2023. Both reports are... |
| 21.03.2024 | ADDvise issues new USD senior secured bonds and partially repurchases outstanding SEK senior secured bonds | ADDvise issues new USD senior secured bonds and partially repurchases outstanding SEK senior secured bonds
Thu, Mar 21, 2024 17:06 CET Report this content
ADDvise Group AB (publ) (the “Company”) announces today that it has successfully plac... |
| 18.03.2024 | ADDvise considers issuance of new USD senior secured bonds and partial buy-back offer in outstanding SEK senior secured bonds | ADDvise considers issuance of new USD senior secured bonds and partial buy-back offer in outstanding SEK senior secured bonds
Mon, Mar 18, 2024 07:45 CET Report this content
ADDvise Group AB (publ) (“ADDvise” or the “Company”) has mandated ... |
| 14.03.2024 | ADDvise Group completes a directed new share issue of B shares of approximately SEK 100 million | ADDvise Group completes a directed new share issue of B shares of approximately SEK 100 million
Thu, Mar 14, 2024 23:00 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR ... |
| 14.03.2024 | ADDvise Group explores the conditions for carrying out a directed new share issue of B shares of approximately SEK 100 million | ADDvise Group explores the conditions for carrying out a directed new share issue of B shares of approximately SEK 100 million
Thu, Mar 14, 2024 17:31 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART,... |
| 22.02.2024 | Year-end report 2023, January 1-December 31 | Year-end report 2023, January 1-December 31
Thu, Feb 22, 2024 07:45 CET Report this content
ADDvise delivers its strongest quarter to date and surpasses financial targets for 2023. Net sales increased by 24% and EBITDA amounted to a record ... |
| 08.02.2024 | Invitation to presentation of year-end report January 1 – December 31, 2023 | Invitation to presentation of year-end report January 1 – December 31, 2023
Thu, Feb 08, 2024 14:00 CET Report this content
ADDvise Group’s year-end report for the period January 1 – December 31, 2023 will be published on February 22, 2024 ... |
| 16.01.2024 | ADDvise receives order worth EUR 2.1 million | ADDvise receives order worth EUR 2.1 million
Tue, Jan 16, 2024 07:30 CET Report this content
ADDvise Group’s subsidiary Labplan has received an order from the pharmaceutical company Eli Lilly.
The order is worth approximately EUR 2.1 millio... |
| 04.01.2024 | ADDvise receives order worth USD 2.5 million | ADDvise receives order worth USD 2.5 million
Thu, Jan 04, 2024 16:00 CET Report this content
ADDvise Group’s subsidiary MRC Systems has received an order from SaudiVax. The company is a biotechnology company specialized in the development a... |
| 29.12.2023 | ADDvise receives order worth USD 3 million | ADDvise receives order worth USD 3 million
Fri, Dec 29, 2023 14:10 CET Report this content
ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Leader Life Sciences, part of Dubai-based Leader Healthcare Group. Leader Li... |
| 26.10.2023 | Interim report 2023, January 1-September 30 | Interim report 2023, January 1-September 30
Thu, Oct 26, 2023 07:45 CET Report this content
July-September 2023
Net revenue for the period was SEK 321.1 million (237.0), an increase of 35.5%. Organic growth was 18.0%.
Orders received for th... |
| 12.10.2023 | Invitation to presentation of interim report July 1 – September 30, 2023 | Invitation to presentation of interim report July 1 – September 30, 2023
Thu, Oct 12, 2023 14:00 CET Report this content
ADDvise Group’s interim report for the period July 1 – September 30, 2023 will be published on October 26, 2023 at 07:4... |
| 01.08.2023 | ADDvise receives order worth USD 4 million | ADDvise receives order worth USD 4 million
Tue, Aug 01, 2023 16:55 CET Report this content
ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Tecnimont. The order involves the design endorsement, supply, and installati... |
| 20.07.2023 | Interim report 2023, January 1-June 30 | Interim report 2023, January 1-June 30
Thu, Jul 20, 2023 07:45 CET Report this content
April-June 2023
Net revenue for the period was SEK 344.4 million (231.9), an increase of 48.5%. Organic growth was 10.4%.
Orders received for the period ... |
| 06.07.2023 | Invitation to presentation of interim report April 1 – June 30, 2023 | Invitation to presentation of interim report April 1 – June 30, 2023
Thu, Jul 06, 2023 16:12 CET Report this content
Stockholm, July 6, 2023
Invitation to presentation of interim report April 1 – June 30, 2023
Media, investors and analysts ... |
| 12.05.2023 | ADDvise extends the agreement with Laborie at a value of SEK 48 million | ADDvise extends the agreement with Laborie at a value of SEK 48 million
Fri, May 12, 2023 08:40 CET Report this content
ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The a... |
| 24.04.2023 | ADDvise Group completes a directed share issue of approximately SEK 100 million | ADDvise Group completes a directed share issue of approximately SEK 100 million
Mon, Apr 24, 2023 22:20 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED ... |
| 20.04.2023 | Interim report 2023, January 1-March 31 | Interim report 2023, January 1-March 31
Thu, Apr 20, 2023 07:45 CET Report this content
January-March 2023
Net revenue for the period was SEK 310.5 million (162.4), an increase of 91.2%. Organic growth was 19.7%.
Orders received for the per... |
| 05.04.2023 | Invitation to presentation of interim report January 1 – March 31, 2023 | Invitation to presentation of interim report January 1 – March 31, 2023
Wed, Apr 05, 2023 14:27 CET Report this content
Media, investors and analysts are on the same day invited to attend a presentation of the interim report January 1 – Mar... |
| 23.02.2023 | Year-end report 2022, January 1-December 31 | Year-end report 2022, January 1-December 31
Thu, Feb 23, 2023 07:45 CET Report this content
October–December 2022
Net revenue for the period was SEK 320.3 million (155.0), an increase of 106.6 %. Organic growth was 5.5 %.
Orders received fo... |
| 16.02.2023 | ADDvise receives allocation decision worth approximately SEK 48 million | ADDvise receives allocation decision worth approximately SEK 48 million
Thu, Feb 16, 2023 16:50 CET Report this content
ADDvise Group AB (publ)’s subsidiary Hettich Labinstrument AB has received an allocation decision from Region Västra Göt... |
| 20.01.2023 | ADDvise receives order worth USD 3.5 million | ADDvise receives order worth USD 3.5 million
Fri, Jan 20, 2023 21:05 CET Report this content
ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment a... |
| 19.01.2023 | ADDvise receives order worth USD 1.8 million | ADDvise receives order worth USD 1.8 million
Thu, Jan 19, 2023 16:48 CET Report this content
ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a l... |
| 20.12.2022 | ADDvise receives order worth USD 1.2 million | ADDvise receives order worth USD 1.2 million
Tue, Dec 20, 2022 20:40 CET Report this content
ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an additional order from Cochran Wholesale Pharmaceuticals, a generic pharmaceu... |
| 19.12.2022 | ADDvise receives order worth USD 1.5 million | ADDvise receives order worth USD 1.5 million
Mon, Dec 19, 2022 16:40 CET Report this content
ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from Wellgistics, a pharmaceutical wholesale distributor delivering to... |
| 16.12.2022 | ADDvise receives order worth USD 2.1 million | ADDvise receives order worth USD 2.1 million
Fri, Dec 16, 2022 07:15 CET Report this content
ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from Cochran Wholesale Pharmaceuticals, a generic pharmaceutical whole... |
| 15.12.2022 | Bondholders approve amendment to bond terms and conditions | Bondholders approve amendment to bond terms and conditions
Thu, Dec 15, 2022 17:30 CET Report this content
ADDvise Group AB (publ) (the "Company") today announces the successful completion of the written procedure that was initiat... |
| 24.11.2022 | ADDvise receives order worth USD 1.7 million | ADDvise receives order worth USD 1.7 million
Thu, Nov 24, 2022 16:00 CET Report this content
ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from BioGeneric Pharma, a leading factory in biotechnology based in Cairo, Egyp... |
| 28.10.2022 | Interim report January 1 - September 30, 2022 | Interim report January 1 - September 30, 2022
Fri, Oct 28, 2022 08:15 CET Report this content
July-September 2022
Net revenue for the period was SEK 237.0 million (105.6), an increase of 124.5 %. Organic growth was 27.2 %.
Orders received f... |
| 31.08.2022 | ADDvise receives order worth USD 640,000 | ADDvise receives order worth USD 640,000
Wed, Aug 31, 2022 22:25 CET Report this content
ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Hortman Health Care Investment LLC, an investment company in the private healt... |
| 22.07.2022 | Interim report January 1 – June 30, 2022 | Interim report January 1 – June 30, 2022
Fri, Jul 22, 2022 08:45 CET Report this content
April-June 2022
Orders received for the period was SEK 260.9 million (122.8), an increase of 112.5 %. Organic growth was 22.3 %.
Net revenue for the pe... |
| 19.07.2022 | ADDvise receives allocation decision worth approximately EUR 2.4 million | ADDvise receives allocation decision worth approximately EUR 2.4 million
Tue, Jul 19, 2022 13:15 CET Report this content
ADDvise Group AB (publ)’s subsidiary Sonar Oy has received an allocation decision from Helsinki University Hospital in ... |
| 01.07.2022 | ROSIE APPOINTS NEW PRESIDENT & CEO, HAROLD LANDERS | New Rosie CEO, Harold Landers SAVANNAH, GEORGIA, UNITED STATES, July 1, 2022 /EINPresswire.com/ -- Rosie Connectivity Solutions (ROSIE) headquartered in Savannah, Georgia, announced senior management changes today. Effective July 1, 2022, H... |
| 22.04.2022 | Interim report January 1 – March 31 2022 | Interim report January 1 – March 31 2022
Fri, Apr 22, 2022 08:45 CET Report this content
January-March 2022
Net revenue for the period was SEK 162.4 million (87.7), an increase of 85.1 %. Organic growth was 4.2 %.
Adjusted EBITDA for the pe... |
| 14.03.2022 | ADDvise Group completes a directed new share issue of approximately SEK 100 million which was oversubscribed | ADDvise Group completes a directed new share issue of approximately SEK 100 million which was oversubscribed
Mon, Mar 14, 2022 22:30 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIR... |
| 14.03.2022 | ADDvise Group announces intention to carry out a directed new share issue of approximately SEK 100 million | ADDvise Group announces intention to carry out a directed new share issue of approximately SEK 100 million
Mon, Mar 14, 2022 17:31 CET Report this content
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIREC... |
| 24.02.2022 | Year-end report 2021, January 1 – December 31 | Year-end report 2021, January 1 – December 31
Thu, Feb 24, 2022 08:45 CET Report this content
October - December 2021
Net revenue for the period was SEK 155.0 million (96.8), an increase of 60.1 %. Organic growth was 12.8 %.
Adjusted EBITDA... |
| 22.12.2021 | ADDvise signs Letter of Intent to acquire JTECH Medical Industries, Inc. | ADDvise signs Letter of Intent to acquire JTECH Medical Industries, Inc. Wed, Dec 22, 2021 08:00 CET
ADDvise Group AB (publ) has signed a Letter of Intent with the shareholder of JTECH Medical Industries, Inc. (”JTECH”) regarding an acquisi... |
| 22.12.2021 | ADDvise Group changes listing to Nasdaq First North Premier | ADDvise Group changes listing to Nasdaq First North Premier Wed, Dec 22, 2021 10:48 CET
ADDvise Group has applied to trade on Nasdaq First North Premier and has today received an approval. ADDvise Group changes its listing on 23 December 20... |
| 20.12.2021 | ADDvise Group publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm | ADDvise Group publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm Mon, Dec 20, 2021 17:24 CET
ADDvise Group AB (publ) issued on 5 November 2021 a senior secured bond loan of SEK 250,000,000 within a total fram... |
| 16.12.2021 | ADDvise Group calls for a change of the terms of the company’s senior secured bonds by initiation of a written procedure | ADDvise Group calls for a change of the terms of the company’s senior secured bonds by initiation of a written procedure Thu, Dec 16, 2021 10:21 CET
ADDvise Group AB (publ) (the "Company" and together with its subsidiaries from ti... |
| 27.10.2021 | Interim report 2021, January 1 – September 30 | Interim report 2021, January 1 – September 30 Wed, Oct 27, 2021 08:45 CET
July - September 2021
Net revenue for the period was SEK 105.6 million (76.2), an increase of 38.6 %. Organic growth was 12.1 %.
Adjusted EBITDA for the period was SE... |
| 27.10.2021 | Interim report 2021, January 1 - September 30 | July - September 2021
Net revenue for the period was SEK 105.6 million (76.2), an increase of 38.6 %. Organic growth was 12.1 %.
Adjusted EBITDA for the period was SEK 14.5 million (5.3)
EBITDA for the period was SEK 13.3 million (9.4)
Adju... |
| 30.08.2021 | ADDvise signs Letter of Intent to acquire Southern Life Systems, Inc. | ADDvise signs Letter of Intent to acquire Southern Life Systems, Inc. Mon, Aug 30, 2021 08:30 CET
ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Southern Life Systems, Inc. (”SLS”) regarding an acquisition of... |
| 28.07.2021 | ADDvise Group’s CFO Aaron Wong resigns | ADDvise Group’s CFO Aaron Wong resigns Wed, Jul 28, 2021 13:00 CET
Aaron Wong, CFO and member of the management team of ADDvise Group AB (publ) since October 2018, has today announced that he will step down from his position as Chief Financ... |
| 23.07.2021 | Interim report 2021, January 1 – June 30 | Interim report 2021, January 1 – June 30 Fri, Jul 23, 2021 08:45 CET
April - June 2021
Net revenue for the period was SEK 117.6 million (101.8)
EBITDA for the period was SEK 15.8 million (15.1)
EBITA for the period was SEK 13.3 million (13.... |
| 23.07.2021 | ADDvise : Interim report 2021, January 1 - June 30 | April - June 2021
Net revenue for the period was SEK 117.6 million (101.8)
EBITDA for the period was SEK 15.8 million (15.1)
EBITA for the period was SEK 13.3 million (13.1)
Profit/loss for the period was SEK 0.1 million (8.3)
Basic earning... |
| 24.05.2021 | ADDvise signs Letter of Intent to acquire Medisuite, LLC | ADDvise signs Letter of Intent to acquire Medisuite, LLC Mon, May 24, 2021 08:20 CET
ADDvise Group AB (publ) has signed a Letter of Intent with the shareholders of Medisuite, LLC (”Medisuite”) regarding an acquisition of 100 percent of the ... |
| 21.05.2021 | ADDvise Group to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds | ADDvise Group to redeem its outstanding up to SEK 240,000,000 senior secured callable bonds Fri, May 21, 2021 08:15 CET
ADDvise Group AB (publ) (“ADDvise") hereby announces that ADDvise’s up to SEK 240,000,000 senior unsecured callable... |
| 23.04.2021 | ADDVISE GROUP AB (PUBL)
ADDvise : Interim report 2021, January 1 - March 31 | January - March 2021
Net revenue for the period was SEK 87.7 million (83.7)
EBITDA for the period was SEK 8.9 million (5.4)
EBITA for the period was SEK 6.9 million (3.4)
Profit/loss for the period was SEK 2.5 million (-2.5)
Basic earnings ... |
| 31.03.2021 | ADDvise Group AB (publ) publishes the 2020 annual report – Regulatory information | ADDvise Group AB (publ) publishes the 2020 annual report – Regulatory information Wed, Mar 31, 2021 10:30 CET
Today, on 31 March 2021, ADDvise Group AB (publ) is publishing its annual report for 2020. The annual report is available on ADDvi... |